Genmab A/S (OTCMKTS:GNMSF) stock breaks above 50-day moving average of $312.68
Shares of Genmab A/S (OTCMKTS: GNMSF – Get a rating) crossed above its 50-day moving average during Monday’s trading. The stock has a 50-day moving average of $312.68 and is trading as low as $368.00. Genmab A/S shares last traded at $338.57, with a volume of 453 shares traded.
Genmab A/S shares fall 2.7%
The company’s 50-day moving average is $312.68 and its two-hundred-day moving average is $332.19. The company has a market capitalization of $22.13 billion, a P/E ratio of 60.35 and a beta of 0.79.
Genmab A/S (OTCMKTS: GNMSF – Get a rating) last released its quarterly earnings data on Wednesday, May 11. The company reported earnings per share of $1.06 for the quarter. The company posted revenue of $319.54 million for the quarter. Genmab A/S posted a net margin of 26.34% and a return on equity of 10.90%.
About Genmab A/S
Genmab A/S develops therapeutic antibodies for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.
Get news and reviews for Genmab A/S Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Genmab A/S and related companies with MarketBeat.com’s free daily email newsletter.